C5-benzyl SAHA

CAS No. 2115700-64-4

C5-benzyl SAHA ( —— )

Catalog No. M13367 CAS No. 2115700-64-4

C5-benzyl SAHA is a C5-modified SAHA analog that displays dual selectivity to HDAC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    C5-benzyl SAHA
  • Note
    Research use only, not for human use.
  • Brief Description
    C5-benzyl SAHA is a C5-modified SAHA analog that displays dual selectivity to HDAC.
  • Description
    C5-benzyl SAHA is a C5-modified SAHA analog that displays dual selectivity to HDAC6 (IC50=0.27 uM) and HDAC8 (IC50=0.38 uM) over HDAC 1, 2, and 3 (IC50=2.9-5.8 uM); dose dependently and selectively increases in levels of acetyl-α-tubulin in U937 leukemia cells.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2115700-64-4
  • Formula Weight
    354.45
  • Molecular Formula
    C21H26N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    4-benzyl-N8-hydroxy-N1-phenyloctanediamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Negmeldin AT, et al. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3254-3258.
molnova catalog
related products
  • LB-205

    A Zn2+-dependent pan-inhibitor of class I and class II HDACs with a long half-life (12h) in vivo.

  • HDACi-4b

    A benzamide-type HDAC inhibitor with IC50 of 78 uM for changes of FXN mRNA in affected GM15850 cells.

  • HNHA

    HNHA is an inhibitor of HDAC.